Perbedaan Bakrieland Development Tbk. dan Merck Tbk.: Bakrieland Development Tbk. diperdagangkan di Rp22 (kapitalisasi pasar 1 T, volume 24 jam 28,75 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. lebih besar dari sisi kapitalisasi pasar, dan Bakrieland Development Tbk. lebih aktif diperdagangkan (28,75 jt vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ELTY | MERK | |
|---|---|---|
Kapitalisasi Pasar | 1 T | 1,68 T |
Volume | 28,75 jt | 33,3 rb |
Lot | 287,49 rb | 333 |
Perputaran | 638,29 jt | 126,46 jt |
Harga Rata-rata | 22,2 | 3.797,72 |
Nilai Transaksi | 638,29 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 22 | 3.800 |
Volume Ekuilibrium Indikatif | 65,62 rb | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Selengkapnya di halaman ELTY →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →